Beta-Carotene: The Lung-Cancer Trials (and Why Most Don't Need It)

By Erin Rose · Updated July 19, 2026 · Methodology

Educational overview — not medical advice. Beta-carotene supplements are contraindicated for current/former smokers and anyone with significant asbestos exposure; see the box below before reading further. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

As an Amazon Associate we earn from qualifying purchases. On best beta-carotene, the honest verdict for most people is "skip it" — products are ranked by lower beta-carotene dominance and mixed-carotenoid formulation, not highest IU, and never by commission.

Start here

What beta-carotene is, and the split this whole category hinges on

Beta-carotene is a provitamin-A carotenoid — a plant pigment (the orange in carrots, the deep color in sweet potatoes and dark leafy greens) that the body can convert into vitamin A on an as-needed, regulated basis, with wide inter-individual variation in conversion efficiency (Tang 2010). It is not an essential nutrient itself — there's no RDA and no government-set upper limit for beta-carotene, because unlike preformed vitamin A (retinol), excess beta-carotene from food or standard supplements has not been shown to cause classic vitamin-A toxicity (hepatotoxicity, teratogenicity, bone effects). That "not vitamin-A-toxic" fact is real, but it is not the whole safety story, and conflating the two is the single most common mistake in how this ingredient gets marketed.

The actual safety story is a specific, mechanistically distinct one: in two large randomized controlled trials, high-dose isolated beta-carotene supplementation significantly increased lung cancer risk in smokers. ATBC (Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, 1994, NEJM) randomized 29,133 Finnish male smokers aged 50-69 to alpha-tocopherol, beta-carotene (20mg/day), both, or placebo for 5-8 years; the beta-carotene group had an 18% higher lung cancer incidence and 8% higher total mortality, driven by lung cancer and ischemic heart disease. CARET (Omenn, Goodman, Thornquist, et al., 1996, NEJM) randomized 18,314 smokers, former smokers, and asbestos-exposed workers to 30mg beta-carotene plus 25,000 IU retinyl palmitate per day vs. placebo — and was stopped 21 months early when interim data showed lung cancer incidence up 28% (RR 1.28), lung cancer mortality up 46%, and total mortality up 17% in the treatment arm. The authors concluded the combination "had no benefit and may have had an adverse effect." A 2012 Cochrane meta-analysis of 78 RCTs pooling 296,707 participants (Bjelakovic et al.) confirmed beta-carotene supplementation was associated with significantly increased all-cause mortality across the pooled data — this was not a statistical fluke in two trials.

Food is a genuinely different story — but not a clean one either

Dietary (food-source) beta-carotene intake is associated with lower all-cause mortality in meta-analyses of prospective cohorts: Zhao et al. 2016 found dietary intake associated with a 17% lower mortality risk (RR 0.83) and circulating blood beta-carotene levels associated with an even stronger 31% lower risk (RR 0.69); Aune et al. 2018 found dietary and blood carotenoid levels inversely associated with coronary heart disease, stroke, and cardiovascular disease more broadly. That's a real, food-side counterweight to the supplement-side harm data, and it's the reason this page draws a hard line between "eat the carrot" and "take the pill" rather than treating beta-carotene as uniformly good or uniformly dangerous.

But even the food-side data isn't as clean as it's often presented. Shibata et al. 1992 followed 5,080 men and found that higher dietary beta-carotene intake was associated with lower lung cancer risk in an unadjusted analysis — but that protective association "approached or crossed the null value" once adjusted for personal smoking status. People who eat more produce also tend to smoke less, and a chunk of the apparent food-source benefit is that confound, not beta-carotene itself. The honest summary holds anyway: eat carotenoid-rich food, don't take an isolated high-dose beta-carotene pill, and never take one if you smoke or used to.

The one legitimate medical use, and the harmless side effect

There is a narrow, real, physician-supervised use: high-dose oral beta-carotene (15-180mg/day, titrated) as photoprotective therapy for erythropoietic protoporphyria (EPP) and related photosensitivity diseases, established in a clinical series of 133 patients (Mathews-Roth et al. 1977). This is a disease-specific, clinician-directed therapy at doses well above typical retail products — not a DIY "protect your skin" or "get a natural tan" use, and it should never be cited that way. Separately, high carotenoid intake — from food or supplements — can cause carotenemia/carotenoderma: harmless, reversible yellow-orange skin discoloration (Svensson & Vahlquist 1995) that can also show up in the oral mucosa (Brooks et al. 2025). It's cosmetic only, distinguishable from jaundice because it spares the whites of the eyes, and resolves when intake drops — a minor footnote, not the headline risk.

Compare Beta-Carotene Products by Cost Per Day

If, after reading the contraindication above, a mixed-carotenoid option is still right for you (never if you currently smoke, used to smoke, or have significant asbestos exposure), here's how the products we track compare on cost per day.

Frequently asked questions

Related guides

• Lutein & Zeaxanthin — the carotenoids that replaced beta-carotene in the modern AREDS2 eye formula
• Astaxanthin — another carotenoid-family antioxidant, different evidence base
• Vitamin C — an antioxidant sibling with a very different (supplement-supportive, not supplement-harmful) evidence picture

Sources